Tonix Pharmaceuticals Holding Corp. discloses preliminary operating results for Q2 2024, including net cash used in operating activities of $12.9 million and net revenue of $2.2 million. The company's cash resources and equity offering proceeds may not meet its financial requirements through Q3 2024.